Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1095587


Belgium In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015


Description: Belgium In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Belgium In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market market in Belgium

Scope

- The report provides information on the Belgian in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.
- Total revenues, end users
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the in vitro diagnostics devices market in Belgium.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Contents: 1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 In Vitro Diagnostics
3.2 Clinical Chemistry
3.3 Genetic Testing
3.4 Haematology
3.5 Histology And Cytology
3.6 Immuno Chemistry
3.7 Infectious Immunology
3.8 Microbiology Culture
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval Process
5.2 Notification Fee
6 Pricing and Reimbursement
6.1 Reimbursement Policies
7 Distribution Structure
8 In Vitro Diagnostics In Belgium
8.1 In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), 2000-
8.2 In In Vitro Diagnostics, Belgium, Company Share (2007-2008)
9 Clinical Chemistry In Belgium
9.1 Clinical Chemistry Overall Revenue (2000-2015)
9.2 Clinical Chemistry Distribution Share (2007-2008)
9.3 Clinical Chemistry, Belgium, Company Share (2007-2008)
10 Genetic Testing In Belgium
10.1 Genetic Testing Overall Revenue (2000-2015)
10.2 Genetic Testing Distribution Share (2007-2008)
10.3 Genetic Testing, Belgium, Company Share (2007-2008)
11 Haematology In Belgium
11.1 Haematology Overall Revenue (2000-2015)
11.2 Haematology Distribution Share (2007-2008)
11.3 Haematology, Belgium, Company Share (2007-2008)
12 Histology and Cytology In Belgium
12.1 Histology and Cytology Overall Revenue (2000-2015)
12.2 Histology and Cytology Distribution Share (2007-2008)
12.3 Histology And Cytology, Belgium, Company Share (2007-2008)
13 Immuno Chemistry In Belgium
13.1 Immuno Chemistry Overall Revenue (2000-2015)
13.2 Immuno Chemistry Distribution Share (2007-2008)
13.3 Immuno Chemistry, Belgium, Company Share (2007-2008)
14 Infectious Immunology In Belgium
14.1 Infectious Immunology Overall Revenue (2000-2015)
14.2 Infectious Immunology Distribution Share (2007-2008)
14.3 Infectious Immunology, Belgium, Company Share (2007-2008)
15 Microbiology Culture In Belgium
15.1 Microbiology Culture Overall Revenue (2000-2015)
15.2 Microbiology Culture Distribution Share (2007-2008)
15.3 Microbiology Culture, Belgium, Company Share (2007-2008)
16 Overview of Key Companies in Belgium In Vitro Diagnostics Market
16.1 Ventana Medical Systems, Inc.
16.2 Sysmex Corporation
16.3 Siemens Healthcare
16.4 Qiagen N.V.
16.5 Phadia AB
16.6 Ortho-Clinical Diagnostics Inc.
16.7 OLYMPUS CORPORATION
16.8 Inverness Medical Innovations, Inc.
16.9 Hologic, Inc.
16.10 Gen-Probe Incorporated
16.11 F. Hoffmann-La Roche Ltd.
16.12 DiaSorin S.p.A
16.13 Dade Behring Holdings, Inc.
16.14 Bio-Rad Laboratories, Inc.
16.15 bioMerieux S.A.
16.16 Becton, Dickinson and Company
16.17 Beckman Coulter, Inc.
16.18 Abbott Laboratories
16.19 BioTech Tools
16.20 Euroscreen S.A.
16.21 Immunosource
16.22 CorisBioConcept SPRL
17 Financial Deals Landscape
17.1 Acquisition
17.2 Partnerships
18 Recent Developments
18.1 Government and Public Interest
18.2 Product News
18.3 Other Significant Developments
19 Appendix
19.1 Global Markets Direct Research Methodology
19.2 Secondary Research
19.3 Primary Research
19.4 Models
19.5 Forecasts
19.6 Expert Panel Validation
19.7 Currency Conversion
19.8 Contact Us
19.9 Disclaimer

Executive Summary

1.1 List of Tables
Table 1: Healthcare Expenditure in Belgium, 2000 - 2007 26
Table 2: Hospitals and Hospital Beds in Belgium, 2005 28
Table 3: Number of Doctors by Specialty in Belgium, 2003-2007 29
Table 4: Number of Hospital Wards by Specialty in Belgium, 2003-2007 30
Table 5: Medical Equipment Notification Fee in Belgium, 2007 46
Table 6: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), 2000-2015 49
Table 7: In Vitro Diagnostics, Belgium, Cross-Category Analysis, 2000-2015 50
Table 8: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), Historic, 2000-2008 52
Table 9: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), Forecast, 2008-2015 54
Table 10: In Vitro Diagnostics, Belgium, Company Share by Revenue ($ mn), 2007-2008 55
Table 11: Clinical Chemistry, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008 57
Table 12: Clinical Chemistry, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015 59
Table 13: Clinical Chemistry Analyzers, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 60
Table 14: Clinical Chemistry Analyzers, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 61
Table 15: Urine Analysis, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 62
Table 16: Urine Analysis, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 63
Table 17: Clinical Chemistry, Belgium, Distribution Share by Revenue ($mn), 2007-2008 64
Table 18: Clinical Chemistry, Belgium, Company Share by Revenue ($ mn), 2007-2008 65
Table 19: Genetic Testing, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008 66
Table 20: Genetic Testing, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015 67
Table 21: Genetic Testing, Belgium, Distribution Share by Revenue ($mn), 2007-2008 68
Table 22: Genetic Testing, Belgium, Company Share by Revenue ($ mn), 2007-2008 70
Table 23: Haematology, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008 72
Table 24: Haematology, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015 74
Table 25: Haematology Reagents, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 75
Table 26: Haematology Reagents, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 76
Table 27: Immunohaematology, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 77
Table 28: Immunohaematology, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 78
Table 29: Haemostasis, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 80
Table 30: Haemostasis, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 82
Table 31: Haematology Rapid Tests, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 83
Table 32: Haematology Rapid Tests, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 84
Table 33: Haematology Cell Counters, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 85
Table 34: Haematology Cell Counters, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 86
Table 35: Haematology, Belgium, Distribution Share by Revenue ($mn), 2007-2008 87
Table 36: Haematology, Belgium, Company Share by Revenue ($ mn), 2007-2008 88
Table 37: Histology And Cytology, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008 89
Table 38: Histology And Cytology, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015 90
Table 39: Histology, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 91
Table 40: Histology, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 92
Table 41: Histology and Cytology, Belgium, Distribution Share by Revenue ($mn), 2007-2008 93
Table 42: Histology And Cytology, Belgium, Company Share by Revenue ($ mn), 2007-2008 94
Table 43: Immuno Chemistry, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008 96
Table 44: Immuno Chemistry, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015 98
Table 45: Disease Specific Immunochemistry, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 100
Table 46: Disease Specific Immunochemistry, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 102
Table 47: Drug Related Testing, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 103
Table 48: Drug Related Testing, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 104
Table 49: Endocrinology Tests, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 105
Table 50: Endocrinology Tests, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 106
Table 51: Immunochemistry Analyzers, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 108
Table 52: Immunochemistry Analyzers, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 110
Table 53: Immuno Chemistry, Belgium, Distribution Share by Revenue ($mn), 2007-2008 111
Table 54: Immuno Chemistry, Belgium, Company Share by Revenue ($ mn), 2007-2008 113
Table 55: Infectious Immunology, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008 115
Table 56: Infectious Immunology, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015 117
Table 57: Infectious Immunology, Belgium, Distribution Share by Revenue ($mn), 2007-2008 118
Table 58: Infectious Immunology, Belgium, Company Share by Revenue ($ mn), 2007-2008 120
Table 59: Microbiology Culture, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008 122
Table 60: Microbiology Culture, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015 124
Table 61: Microbiology Analyzers, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 125
Table 62: Microbiology Analyzers, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 126
Table 63: Microbiology Culture, Belgium, Distribution Share by Revenue ($mn), 2007-2008 127
Table 64: Microbiology Culture, Belgium, Company Share by Revenue ($ mn), 2007-2008 129
Table 65: Sysmex Corporation Pipeline Products by Equipment Type 130
Table 66: Sysmex Corporation Pipeline Products By Development Stage 130
Table 67: Sysmex Corporation Pipeline Products By Therapy Area 131
Table 68: Sysmex Corporation Pipeline Products By News Summary 131
Table 69: Qiagen N.V. Pipeline Products by Equipment Type 133
Table 70: Qiagen N.V. Pipeline Products By Development Stage 133
Table 71: Qiagen N.V. Pipeline Products By Therapy Area 134
Table 72: Qiagen N.V. Pipeline Products By News Summary 134
Table 73: Phadia AB Pipeline Products by Equipment Type 135
Table 74: Phadia AB Pipeline Products By Development Stage 135
Table 75: Phadia AB Pipeline Products By Therapy Area 136
Table 76: Phadia AB Pipeline Products By News Summary 136
Table 77: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 137
Table 78: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage 138
Table 79: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area 138
Table 80: Inverness Medical Innovations, Inc. Pipeline Products by Equipment Type 140
Table 81: Inverness Medical Innovations, Inc. Pipeline Products By Development Stage 140
Table 82: Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area 141
Table 83: Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials 141
Table 84: Inverness Medical Innovations, Inc. Pipeline Products By News Summary 141
Table 85: Hologic, Inc. Pipeline Products by Equipment Type 142
Table 86: Hologic, Inc. Pipeline Products By Development Stage 143
Table 87: Hologic, Inc. Pipeline Products By Therapy Area 143
Table 88: Hologic, Inc. Pipeline Products By Clinical Trials 143
Table 89: Hologic, Inc. Pipeline Products By News Summary 144
Table 90: Gen-Probe Incorporated Pipeline Products by Equipment Type 145
Table 91: Gen-Probe Incorporated Pipeline Products By Development Stage 146
Table 92: Gen-Probe Incorporated Pipeline Products By Therapy Area 146
Table 93: Gen-Probe Incorporated Pipeline Products By Clinical Trials 146
Table 94: Gen-Probe Incorporated Pipeline Products By News Summary 147
Table 95: DiaSorin S.p.A Pipeline Products by Equipment Type 149
Table 96: DiaSorin S.p.A Pipeline Products By Development Stage 149
Table 97: DiaSorin S.p.A Pipeline Products By Therapy Area 149
Table 98: Becton, Dickinson and Company Pipeline Products by Equipment Type 152
Table 99: Becton, Dickinson and Company Pipeline Products By Development Stage 153
Table 100: Becton, Dickinson and Company Pipeline Products By Therapy Area 153
Table 101: Becton, Dickinson and Company Pipeline Products By Clinical Trials 154
Table 102: Becton, Dickinson and Company Pipeline Products By News Summary 154
Table 103: Beckman Coulter, Inc. Pipeline Products by Equipment Type 155
Table 104: Beckman Coulter, Inc. Pipeline Products By Development Stage 156
Table 105: Beckman Coulter, Inc. Pipeline Products By Therapy Area 157
Table 106: Beckman Coulter, Inc. Pipeline Products By News Summary 157
Table 107: Abbott Laboratories Pipeline Products by Equipment Type 158
Table 108: Abbott Laboratories Pipeline Products By Development Stage 158
Table 109: Abbott Laboratories Pipeline Products By Therapy Area 158
Table 110: Biofield Acquires Minority Stake In ValiBIO From ValiRx 161
Table 111: Solvay Pharmaceuticals Acquires Innogenetics 162
Table 112: IVAX Diagnostics Signs Distribution Agreement With Augurix 163
Table 113: ValiBIO Enters Into An Agreement With Biofield 164
Table 114: USD to Local Currency, Average Exchange Rate 2008 173


Companies Mentioned Ventana Medical Systems, Inc. Sysmex Corporation Siemens Healthcare Qiagen N.V. Phadia AB Ortho-Clinical Diagnostics Inc. OLYMPUS CORPORATION Inverness Medical Innovations, Inc. Hologic, Inc. Gen-Probe Incorporated F. Hoffmann-La Roche Ltd. DiaSorin S.p.A Dade Behring Holdings, Inc. Bio-Rad Laboratories, Inc. bioMerieux S.A. Becton, Dickinson and Company Beckman Coulter, Inc. Abbott Laboratories BioTech Tools Euroscreen S.A. Immunosource CorisBioConcept SPRL


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/1095587

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 13/02/2012 01:28:06
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Belgium In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015
Web Address:
http://www.researchandmarkets.com/reports/1095587
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €1,911.00
Electronic (PDF) - Site License €3,821.00
Electronic (PDF) - Enterprisewide €5,732.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 13/02/2012 01:28:06

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)